MacroGenics Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | -1,163.8% | – | – | – | – | – | – | – | |
| – | +57.1% | +165.7% | -5.0% | +26.7% | +18.4% | +10.3% | -5.8% | +5.4% | -18.7% | -21.8% | -26.7% | |
| – | +141.9% | +55.0% | +21.2% | +12.0% | +18.5% | +5.6% | +11.8% | -11.6% | -10.1% | +60.2% | -51.5% | |
| – | +141.9% | +55.0% | +21.2% | +12.0% | +9.6% | +14.2% | +21.7% | -7.3% | – | – | – | |
| – | -1,204.7% | – | – | -154.6% | – | – | – | -134.9% | – | -97.4% | -2,135.3% | |
| – | +157.5% | +23.7% | +158.4% | -15.1% | -82.8% | +37.7% | +5.0% | -41.6% | -51.3% | +110.1% | -48.4% | |
| – | +4,158.3% | -53.8% | – | -27.3% | -240.1% | -90.2% | +370.3% | – | -213.2% | – | -176.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +52.6% | +34.5% | +2.6% | +550.0% | -100.0% | – | – | -99.1% | -128.2% | – | – | |
| – | +163.9% | -99.1% | +1,806.6% | +197.0% | +14.3% | +45.3% | -29.6% | -98.6% | +8,963.4% | -99.4% | +7,141.0% | |
| – | -6.2% | -390.5% | – | -93.4% | -1,214.8% | – | -205.5% | – | – | – | -253.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.